Pilgrim's Pride Corporation PPC
Composite 51/100; the shares have moved about 40% annualised. Names that move more contribute more risk for the same amount invested, and our composite reflects how strong the evidence for this one is right now.
Momentum ranks 26/100 — a moderate mark against it.
Valuation ranks 74/100 — a moderate point in its favour. Balance-sheet strength ranks 58/100 — a slight point in its favour.
Momentum ranks 26/100 — a moderate mark against it. Growth ranks 36/100 — a moderate mark against it. Quality ranks 50/100 — a slight mark against it.
What the company does Pilgrim’s Pride Corporation (PPC) processes and markets fresh, frozen, and value-added chicken and pork products across the U.S., Europe, and Mexico under brands such as Pilgrim’s, Just BARE, and Gold’n Plump. Its portfolio spans refrigerated cuts, fully cooked meals, plant-based proteins, and multi-protein frozen foods for retail, foodservice, and export markets.
Key financials PPC posts strong returns (ROE 25.8%, ROA 9.3%, ROCE 18.7%) but thin margins (gross 11.6%, operating 4.2%, net 4.8%) amid revenue growth of 1.6% and EPS down 65.6%. Leverage is moderate (debt/equity 0.81, net debt/EBITDA 1.67) with solid interest coverage of 8.90 and current ratio of 1.35.
Stock health Momentum is weak: -16.57% over 3 months, -36.41% over 6 months, and -39.45% over 12 months, with RSI(14) at 42.40. Quality scores are average (Quality 57.8), growth is poor (Growth 11.3), but valuation is attractive (Valuation 82.6).
Price vs fair value PPC trades at a discount of 93.50% to our fair-value estimate of 53.43 and a discount of 21.56% to the 12-month analyst target of 33.56. - Q2 CY2026 earnings missed estimates on commodity pricing pressure (Zacks, 2026-07-30) - WSJ highlights a chicken glut pressuring poultry companies (WSJ, 2026-07-30) - PPC reported lower profit and sales in Q2 (WSJ, 2026-07-29) - Analysts expected sales to fall short ahead of the report (StockStory, 2026-07-28)
Looking forward Forward P/E of 7.75 and EV/EBITDA of 5.15 suggest deep value, but weak growth (Growth 11.3) and negative EPS momentum warrant caution. The company’s strong returns and low valuation contrast with recent top-line and margin headwinds.
This is not investment advice. Sideravia provides automated, data-driven analysis for information and education only. Nothing on this page is a personal recommendation or an invitation to buy or sell any security, and it does not consider your objectives or financial situation. Assessments are generated by rules applied uniformly to every covered stock — how our scores work.
Data as of 2026-09-03, compiled from third-party sources; errors and delays are possible and figures are not warranted. Investing puts your capital at risk; past performance does not predict future results. We publish our full track record, including the calls that lost, and our conflicts of interest.